Literature DB >> 26634882

Improved wound management at lower cost: a sensible goal for Australia.

Rosana E Norman1,2, Michelle Gibb2, Anthony Dyer2, Jennifer Prentice3, Stephen Yelland4, Qinglu Cheng1, Peter A Lazzarini5,6, Keryln Carville7,8, Karen Innes-Walker1, Kathleen Finlayson1, Helen Edwards1,2, Edward Burn1, Nicholas Graves1.   

Abstract

Chronic wounds cost the Australian health system at least US$2·85 billion per year. Wound care services in Australia involve a complex mix of treatment options, health care sectors and funding mechanisms. It is clear that implementation of evidence-based wound care coincides with large health improvements and cost savings, yet the majority of Australians with chronic wounds do not receive evidence-based treatment. High initial treatment costs, inadequate reimbursement, poor financial incentives to invest in optimal care and limitations in clinical skills are major barriers to the adoption of evidence-based wound care. Enhanced education and appropriate financial incentives in primary care will improve uptake of evidence-based practice. Secondary-level wound specialty clinics to fill referral gaps in the community, boosted by appropriate credentialing, will improve access to specialist care. In order to secure funding for better services in a competitive environment, evidence of cost-effectiveness is required. Future effort to generate evidence on the cost-effectiveness of wound management interventions should provide evidence that decision makers find easy to interpret. If this happens, and it will require a large effort of health services research, it could be used to inform future policy and decision-making activities, reduce health care costs and improve patient outcomes.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Australia; Chronic wounds; Cost-effectiveness analysis; Leg ulcer; Wound management

Mesh:

Year:  2015        PMID: 26634882      PMCID: PMC7949577          DOI: 10.1111/iwj.12538

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  65 in total

1.  Preventing pressure ulcers in long-term care: a cost-effectiveness analysis.

Authors:  Ba' Pham; Anita Stern; Wendong Chen; Beate Sander; Ava John-Baptiste; Hla-Hla Thein; Tara Gomes; Walter P Wodchis; Ahmed Bayoumi; Márcio Machado; Steven Carcone; Murray Krahn
Journal:  Arch Intern Med       Date:  2011-09-26

2.  Estimating the costs associated with the management of patients with chronic wounds using linked routine data.

Authors:  Ceri J Phillips; Ioan Humphreys; Jacqui Fletcher; Keith Harding; George Chamberlain; Steven Macey
Journal:  Int Wound J       Date:  2015-03-26       Impact factor: 3.315

3.  A limb lost every 3 hours: can Australia reduce amputations in people with diabetes?

Authors:  Shan M Bergin; Jan B Alford; Bernard P Allard; Joel M Gurr; Emma L Holland; Mark W Horsley; Maarten C Kamp; Peter A Lazzarini; Vanessa L Nube; Ashim K Sinha; Jason T Warnock; Paul R Wraight
Journal:  Med J Aust       Date:  2012-08-20       Impact factor: 7.738

4.  Cost-of-illness of chronic leg ulcers in Germany.

Authors:  Sandra Purwins; Katharina Herberger; Eike Sebastian Debus; Stephan J Rustenbach; Peter Pelzer; Eberhard Rabe; Elmar Schäfer; Rudolf Stadler; Matthias Augustin
Journal:  Int Wound J       Date:  2010-04       Impact factor: 3.315

5.  Chronic venous leg ulcers: effect of a community nursing intervention on pain and healing.

Authors:  Helen Edwards; Mary Courtney; Kathleen Finlayson; Ellie Lindsay; Coroline Lewis; Patricia Shuter; Allan Chang
Journal:  Nurs Stand       Date:  2005 Sep 7-13

6.  Diabetes-related lower-limb amputations in Australia.

Authors:  C B Payne
Journal:  Med J Aust       Date:  2000-10-02       Impact factor: 7.738

7.  A cost-effectiveness analysis of two community models of care for patients with venous leg ulcers.

Authors:  L Gordon; H Edwards; M Courtney; K Finlayson; P Shuter; E Lindsay
Journal:  J Wound Care       Date:  2006-09       Impact factor: 2.072

8.  Evaluating the effect of the new incentive system for high-risk pressure ulcer patients on wound healing and cost-effectiveness: a cohort study.

Authors:  Hiromi Sanada; Gojiro Nakagami; Yuko Mizokami; Yukiko Minami; Aya Yamamoto; Makoto Oe; Toshiko Kaitani; Shinji Iizaka
Journal:  Int J Nurs Stud       Date:  2009-09-12       Impact factor: 5.837

9.  Reduced Incidence of Foot-Related Hospitalisation and Amputation amongst Persons with Diabetes in Queensland, Australia.

Authors:  Peter A Lazzarini; Sharon R O'Rourke; Anthony W Russell; Patrick H Derhy; Maarten C Kamp
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

10.  Describing and analysing primary health care system support for chronic illness care in Indigenous communities in Australia's Northern Territory - use of the Chronic Care Model.

Authors:  Damin Si; Ross Bailie; Joan Cunningham; Gary Robinson; Michelle Dowden; Allison Stewart; Christine Connors; Tarun Weeramanthri
Journal:  BMC Health Serv Res       Date:  2008-05-28       Impact factor: 2.655

View more
  14 in total

1.  Reimbursement for the cost of compression therapy for the management of venous leg ulcers in Australia.

Authors:  Rosana E Pacella; Ruth Tulleners; Laura McCosker; Qinglu Cheng; Keith Harding; Helen Edwards; Stephen Yelland; Anthony Dyer; William McGuiness; Nicholas Graves
Journal:  Int Wound J       Date:  2019-05-29       Impact factor: 3.315

2.  Pressure injuries among admissions to a hospital in the tropics.

Authors:  Nicholas Graves; Raju Maiti; Fazila Abu Bakar Aloweni; Ang Shin Yuh; Zhiwen Joseph Lo; Keith Harding
Journal:  Int Wound J       Date:  2020-07-27       Impact factor: 3.315

3.  Randomised controlled trials as part of clinical care: A seven-step routinisation framework proposal.

Authors:  Victoria Team; Carolina D Weller
Journal:  Int Wound J       Date:  2018-12-19       Impact factor: 3.315

4.  A cost-effectiveness analysis of optimal care for diabetic foot ulcers in Australia.

Authors:  Qinglu Cheng; Peter A Lazzarini; Michelle Gibb; Patrick H Derhy; Ewan M Kinnear; Edward Burn; Nicholas Graves; Rosana E Norman
Journal:  Int Wound J       Date:  2016-08-04       Impact factor: 3.315

5.  Health benefits of an innovative model of care for chronic wounds patients in Queensland.

Authors:  Ruth Tulleners; David Brain; Xing Lee; Qinglu Cheng; Nicholas Graves; Rosana E Pacella
Journal:  Int Wound J       Date:  2018-11-11       Impact factor: 3.315

6.  Effect of low-level laser therapy on angiogenesis and matrix metalloproteinase-2 immunoexpression in wound repair.

Authors:  Melyssa Lima de Medeiros; Irami Araújo-Filho; Efigênia Maria Nogueira da Silva; Wennye Scarlat de Sousa Queiroz; Ciro Dantas Soares; Maria Goretti Freire de Carvalho; Maria Aparecida Medeiros Maciel
Journal:  Lasers Med Sci       Date:  2016-09-20       Impact factor: 3.161

7.  Measuring costs and quality of life for venous leg ulcers.

Authors:  Louise Barnsbee; Qinglu Cheng; Ruth Tulleners; Xing Lee; David Brain; Rosana Pacella
Journal:  Int Wound J       Date:  2018-10-05       Impact factor: 3.315

8.  Evaluation of a multifactorial approach to reduce the prevalence of pressure injuries in regional Australian acute inpatient care settings.

Authors:  Sarah K Smith; Samantha E Ashby; Lynette Thomas; Felicity Williams
Journal:  Int Wound J       Date:  2017-11-07       Impact factor: 3.315

9.  Rationale for participation in venous leg ulcer clinical research: Patient interview study.

Authors:  Carolina D Weller; Catelyn Richards; Louise Turnour; Victoria Team
Journal:  Int Wound J       Date:  2020-07-13       Impact factor: 3.315

10.  International study to develop the WOUND-Q patient-reported outcome measure for all types of chronic wounds.

Authors:  Anne F Klassen; Emiel L W G van Haren; Tert C van Alphen; Stefan Cano; Karen M Cross; Anne-Margreet van Dishoeck; Kenneth L Fan; Maarten Michael Hoogbergen; Dennis Orgill; Lotte Poulsen; Jens Ahm Sørensen; Lee Squitieri; Elena Tsangaris; Dalibor Vasilic; Andrea L Pusic
Journal:  Int Wound J       Date:  2021-03-10       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.